Reviewed 10 cases. Genomic profiling results guided several treatment decisions.

Reviewed 5 cases. Radiation therapy field and dose adjustments recommended.

Reviewed 5 cases. Multidisciplinary treatment planning discussed for all patients.

Reviewed 12 cases. Multidisciplinary treatment planning discussed for all patients.

Reviewed 10 cases. Supportive care needs and toxicity management addressed.

Reviewed 5 cases. Palliative care integration discussed for advanced-stage patients.

Reviewed 6 cases. Imaging surveillance protocols updated per new NCCN guidelines.

Reviewed 5 cases. Genomic profiling results guided several treatment decisions.

Reviewed 7 cases. Biomarker-driven therapy selection emphasized across the session.

Reviewed 14 cases. Supportive care needs and toxicity management addressed.

Reviewed 12 cases. Biomarker-driven therapy selection emphasized across the session.

Reviewed 10 cases. Supportive care needs and toxicity management addressed.

Reviewed 9 cases. Palliative care integration discussed for advanced-stage patients.

Reviewed 8 cases. Multidisciplinary treatment planning discussed for all patients.

Reviewed 6 cases. Palliative care integration discussed for advanced-stage patients.

Reviewed 11 cases. Genomic profiling results guided several treatment decisions.

Reviewed 11 cases. Multidisciplinary treatment planning discussed for all patients.

Reviewed 6 cases. Imaging surveillance protocols updated per new NCCN guidelines.

Reviewed 8 cases. Radiation therapy field and dose adjustments recommended.

Reviewed 5 cases. Imaging surveillance protocols updated per new NCCN guidelines.

Reviewed 12 cases. Multidisciplinary treatment planning discussed for all patients.

Reviewed 5 cases. Genomic profiling results guided several treatment decisions.

Reviewed 9 cases. Supportive care needs and toxicity management addressed.

Reviewed 7 cases. Imaging surveillance protocols updated per new NCCN guidelines.

Reviewed 7 cases. Biomarker-driven therapy selection emphasized across the session.

Reviewed 11 cases. Palliative care integration discussed for advanced-stage patients.

Reviewed 5 cases. Genomic profiling results guided several treatment decisions.

Reviewed 13 cases. Palliative care integration discussed for advanced-stage patients.